Investor Presentaiton
NZ$ Million
Delivering growth in a COVID-19 headwind
Total revenue from operations
NZ$ Millions
$120.0
$100.0
■1H
$113.1
$105.6
$85.1
$80.0
$80.0
$64.0
$69.0
$60.0
$40.0
$55.5
$48.8
$20.0
$0.0
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
1H 2022
Operating profit
Net profit before tax
$12.0
$11.4
$10.0
1H
$10.7
$7.9
$8.0
$10.0
$8.0
$6.0
$6.1
$6.0
$4.0
NZ$Million
$4.0
$3.1
$2.0
$2.0
$5.5
$2.4
$4.2
$1.2
$0.0
$0.0
-$2.0
FY2019
FY2020*
FY2021
1H 2022
$(2.3)
-$4.0
FY2019
FY2020*
FY2021
1H 2022
AFTpharmaceuticals
*FY2020 operating profit and net profit before tax exclude one-off non-cash $9.8 revaluation gain on the revaluation of Pascomer assets.
For further detail see page 34 of AFT Pharmaceuticals' FY2021 annual report.
1H
Page 3View entire presentation